| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 81.783 | 119.051 | 91.809 | 102.927 | 106.364 | 120.642 | 133.411 | 121.546 | 126.276 |
| Total Income - EUR | - | 81.783 | 119.051 | 91.812 | 102.927 | 106.364 | 120.642 | 133.411 | 121.573 | 126.276 |
| Total Expenses - EUR | - | 4.472 | 8.231 | 11.959 | 30.102 | 28.555 | 29.228 | 32.926 | 22.640 | 35.439 |
| Gross Profit/Loss - EUR | - | 77.311 | 110.820 | 79.853 | 72.825 | 77.809 | 91.415 | 100.485 | 98.932 | 90.837 |
| Net Profit/Loss - EUR | - | 75.675 | 109.630 | 78.935 | 71.796 | 76.823 | 90.232 | 99.177 | 97.741 | 87.125 |
| Employees | - | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Sofigin Med 2015 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 49.093 | 36.107 | 26.704 | 13.297 | 3.844 | 2.516 | 3.437 |
| Current Assets | - | 76.660 | 170.046 | 134.827 | 75.216 | 59.051 | 78.288 | 96.728 | 95.991 | 86.001 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 728 | 1.219 | 1.276 | 44.037 | 47.149 | 77.679 | 52.094 | 69.639 |
| Cash | - | 76.660 | 169.317 | 133.608 | 73.939 | 15.014 | 31.139 | 18.035 | 43.897 | 16.361 |
| Shareholders Funds | - | 75.706 | 168.616 | 183.948 | 108.220 | 84.193 | 90.281 | 99.226 | 97.789 | 87.173 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 953 | 1.429 | 1.366 | 4.400 | 2.720 | 2.421 | 1.349 | 1.724 | 2.470 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sofigin Med 2015 Srl